1323-1334
Review
Role of IL-21 in immune-regulation and tumor immunotherapy
Emma di Carlo, Daniela de Totero, Tiziana Piazza, Marina Fabbi and Silvano Ferrini
1335-1344
Original Article
Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor
Karin Tegerstedt, Andrea Franzén, Torbjörn Ramqvist and Tina Dalianis
1345-1357
Original Article
The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs
Peter Ravn, Renate Stahn, Antje Danielczyk, Dorian Faulstich and Uwe Karsten, et al.
1359-1366
Original Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33
Satoko Matsueda, Akira Yamada, Yukari Takao, Mayumi Tamura and Nobukazu Komatsu, et al.
1367-1379
Original Article
Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity
Joanne Lysaght, Andrew G. Jarnicki and Kingston H. G. Mills
1381-1395
Original Article
Development of anti-PAX3 immune responses; a target for cancer immunotherapy
Nourredine Himoudi, Steven Nabarro, Mengyong Yan, Kimberly Gilmour and Adrian J. Thrasher, et al.
1397-1406
Original Article
Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial
Herbert Riechelmann, Markus Wiesneth, Peter Schauwecker, Peter Reinhardt and Silke Gronau, et al.
1407-1415
Original Article
Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma
Nicolae-Costin Diaconu, Renata Kaminska, Anita Naukkarinen, Rauno J. Harvima and Gunnar Nilsson, et al.
1417-1428
Original Article
Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors
Henrik Søndergaard, Klaus S. Frederiksen, Peter Thygesen, Elisabeth D. Galsgaard and Kresten Skak, et al.
1429-1442
Original Article
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment
Christoph Bergmann, Laura Strauss, Reinhard Zeidler, Stephan Lang and Theresa L. Whiteside
1443-1458
Original Article
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery
Aleksandra Kowalczyk, Andrzej Wierzbicki, Margaret Gil, Barbara Bambach and Yutaro Kaneko, et al.
1459-1469
Original Article
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor
Andrea Ladányi, Judit Kiss, Beáta Somlai, Katalin Gilde and Zsuzsanna Fejős, et al.
1471-1484
Original Article
The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses
Mala Chakraborty, Jeffrey Schlom and James W. Hodge
1485-1499
Original Article
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
Inge Marie Svane, Anders E. Pedersen, Julia S. Johansen, Hans E. Johnsen and Dorte Nielsen, et al.
1501-1506
Original Article
Open AccessNo evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies
Janet W. de Beukelaar, Georges M. Verjans, Yvette van Norden, Johannes C. Milikan and Jaco Kraan, et al.
1507-1512
Short Communication
Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies
Gustavo Helguera, José A. Rodríguez, Tracy R. Daniels and Manuel L. Penichet